Designing drugs for the treatment of female sexual dysfunction.

Designing drugs for the treatment of female sexual dysfunction.

Item
http://www.wikidata.org/entity/Q36934818
Antidepressants and sexual dysfunction: mechanisms and clinical implications.Predictability of intranasal pharmacokinetics in man using pre-clinical pharmacokinetic data with a dopamine 3 receptor agonist, PF-219061.Female sexual dysfunction: therapeutic options and experimental challenges.Comparison of Elaeagnus angustifolia Extract and Sildenafil Citrate on Female Orgasmic Disorders: A Randomized Clinical Trial.Cyclic lactam hybrid α-MSH/Agouti-related protein (AGRP) analogues with nanomolar range binding affinities at the human melanocortin receptorsReview of drug treatment for female sexual dysfunction.Review of low libido in women.Exploration of therapeutic targets for sexual dysfunctions: lessons learned from the failed stories.Comparison of the Effects of Elaeagnus angustifolia Flower Capsule and Sildenafil Citrate Tablet on Anxiety Resulting From Sexual Dysfunction in Women Referring to the Selected Clinics of Shiraz University of Medical Sciences.Female sexual dysfunction: reality or disease-mongering?
P2860

Designing drugs for the treatment of female sexual dysfunction.

Item
http://www.wikidata.org/entity/Q36934818
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Designing drugs for the treatment of female sexual dysfunction.
@en
type
label
Designing drugs for the treatment of female sexual dysfunction.
@en
prefLabel
Designing drugs for the treatment of female sexual dysfunction.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Designing drugs for the treatment of female sexual dysfunction.
@en
P2093
P304
P31
P356
10.1016/J.DRUDIS.2007.07.007
P433
P478
P577
P698